Literature DB >> 32535340

Prognostic value of log odds of positive lymph nodes in patients with resectable oral squamous cell carcinoma.

Wanyong Jin1, Zaiou Zhu1, Yuanyuan Wu1, Xu Ding1, Heming Wu1, Xiaomeng Song2, Yunong Wu3.   

Abstract

OBJECTIVES: Log odds of positive lymph nodes (LODDS) was reported to be significantly associated with prognosis in several malignant tumors. However, few are the studies on the correlation between LODDS and overall survival (OS) in patients with oral squamous cell carcinoma (OSCC).
MATERIALS AND METHODS: A retrospective study including 233 patients with OSCC during 2009 to 2013 was conducted. We probed the correlation between clinicopathological factor, LODDS, lymph node ratio (LNR), pN and OS. The potential prognostic factor and the independent factor were calculated using univariate analysis and multivariate analysis respectively. The goodness of fit and the discriminability was analyzed with Somer's D value, Nagelkerke R2 index, and Akaike information criterion (AIC). Kaplan-Meier survival curve of OS was contrasted by log-rank test in LODDS, LNR and pN, respectively.
RESULTS: According to the X-tile, the cut-off values are -1.491 and -0.763 for LODDS, 0.024 and 0.133 for LNR. LODDS, LNR and pN were significantly correlated with OS by univariate analysis (P < 0.001). Multivariate analysis demonstrated LODDS, LNR and pN as an independent prognostic factors for OS (P < 0.01). Compared with pN and LNR models, LODDS showed the strongest predictive power. LODDS was superior to LNR and pN in predicting outcomes in patients with no positive lymph nodes and inadequate neck dissection.
CONCLUSION: LODDS would be incorporated into future N classification, which may be conducive to discern the prognosis of OSCC and make a decision of adjuvant therapy in clinical practice.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Log odds of positive lymph nodes; Lymph node ratio; N classification; Overall survival; Resectable oral cancer

Mesh:

Year:  2020        PMID: 32535340     DOI: 10.1016/j.oraloncology.2020.104709

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  5 in total

1.  The Evaluation of a SEER-Based Nomogram in Predicting the Survival of Patients Treated with Neoadjuvant Therapy Followed by Esophagectomy.

Authors:  Qing Wang; Zhiyong Sun; Xin Xu; Xiumei Ma; Xiaojing Zhao; Qing Ye
Journal:  Front Surg       Date:  2022-06-29

2.  Towards an Improved Pathological Node Classification for Prognostic Stratification of Patients With Oral Cavity Squamous Cell Carcinoma: Results From a Nationwide Registry Study.

Authors:  Chung-Jan Kang; Yu-Wen Wen; Shu-Ru Lee; Shu-Hang Ng; Chi-Ying Tsai; Li-Yu Lee; Ying-Hsia Chu; Chien-Yu Lin; Kang-Hsing Fan; Hung-Ming Wang; Chia-Hsun Hsieh; Chih-Hua Yeh; Chih-Hung Lin; Chung-Kan Tsao; Tuan-Jen Fang; Shiang-Fu Huang; Li-Ang Lee; Ku-Hao Fang; Yu-Chien Wang; Wan-Ni Lin; Li-Jen Hsin; Tzu-Chen Yen; Nai-Ming Cheng; Chun-Ta Liao
Journal:  Front Oncol       Date:  2022-06-28       Impact factor: 5.738

3.  Value of the log odds of positive lymph nodes for prognostic assessment of colon mucinous adenocarcinoma: Analysis and external validation.

Authors:  Huajun Cai; Tianbao Xu; Zhicheng Zhuang; Yiyi Zhang; Yuan Gao; Xing Liu; Jinfu Zhuang; Yuanfeng Yang; Guoxian Guan
Journal:  Cancer Med       Date:  2021-11-18       Impact factor: 4.452

4.  The log odds of positive neck lymph nodes is a superior lymph node predictor for overall survival in head and neck cancer: a population-based analysis in Germany.

Authors:  Mussab Kouka; Elisa Al-Ahmar; Jens Büntzel; Holger Kaftan; Daniel Böger; Andreas Müller; Stefan Schultze-Mosgau; Thomas Ernst; Orlando Guntinas-Lichius
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-11-22       Impact factor: 3.236

5.  A Novel Nomogram Based on Log Odds of Metastatic Lymph Nodes to Predict Overall Survival in Patients With Perihilar Cholangiocarcinoma After Surgery.

Authors:  Wenbo Zou; Chunyu Zhu; Zizheng Wang; Xianglong Tan; Chenggang Li; Zhiming Zhao; Minggen Hu; Rong Liu
Journal:  Front Oncol       Date:  2021-07-22       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.